Cargando…
Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
Information regarding the infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in asymptomatic carriers is scarce. In order to determine the duration of infectivity and its correlation with reverse transcription-PCR (RT-PCR) results and time since initial positive PCR test in...
Autores principales: | Murata, Takayuki, Sakurai, Aki, Suzuki, Masahiro, Komoto, Satoshi, Ide, Tomihiko, Ishihara, Takuma, Doi, Yohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265619/ https://www.ncbi.nlm.nih.gov/pubmed/34011679 http://dx.doi.org/10.1128/mSphere.00019-21 |
Ejemplares similares
-
Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort
por: Suzuki, Masahiro, et al.
Publicado: (2021) -
Natural History of Asymptomatic SARS-CoV-2 Infection
por: Sakurai, Aki, et al.
Publicado: (2020) -
Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021) -
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
por: Aydillo, Teresa, et al.
Publicado: (2020) -
Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)